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Summary. Diabetes in now the commonest cause of 
renal failure in the western world. Furthermore the 
survival of diabetic patients requiring dialysis treatment 
for renal failure is far less than patients with renal failure 
secondary to all other diseases. It is therefore important 
to identify the factors that control the development of 
progressive renal disease to allow targeted therapeutic 
interventions which would have major implications both 
to patient well-being and also to the provision of health 
care world wide. In this review we discuss possible 
metabolic consequences of hyperglycemia and their role 
in the pathogenesis of diabetic nephropathy. We also 
focus on the involvement of the pro-fibrotic cytokine 
Transforming Growth Factor B, and contrast its role in 
the pathogenesis of glomerular and tubulo-interstitial 
changes seen in diabetic nephropathy. 
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Diabetic nephropathy 
Renal impairment is a common complication of both 
insulin dependent (IDDM) and non-insulin dependent 
(NIDDM) diabetes mellitus. In 1985, it was estimated 
that 600 cases of end stage diabetic nephropathy 
occurred in the United Kingdom (10 cases per million 
population) (Joint Working Party on Diabetic Renal 
Failure of the British Diabetic Association, 1988), and 
that a third of all patients starting renal replacement 
therapy in the United States were diabetic (Eggers, 
1988). Nearly 50% of patients with IDDM diagnosed 
before the age of 30 are affected, and of these two thirds 
will progress to end-stage renal failure. 
patients who have diabetes for 40 years (Andersen et al., 
1983). This pattern of risk indicates that accumulation of 
exposure to diabetes is not sufficient to explain the 
development of clinically manifest kidney disease, and 
suggests that only a subset of patients are susceptible to 
renal complications. The cumulative incidence clearly 
indicates that only a proportion of IDDM patients will 
ever develop nephropathy. The ominous significance of 
renal involvement in IDDM is shown by the comparison 
of long term outcome in patients with and without 
nephropathy. Only 10% of patients with proteinuria 
survive after 40 years of diabetes, in contrast to more 
than 70% of those without proteinuria (Andersen et al., 
1983). 
Data on the prevalence and incidence of neprhro- 
pathy in NIDDM were sparse until recently. Unlike 
IDDM, the prevalence of proteinuria increases steadily 
with duration of NIDDM, from 10% in patients with less 
than 5 years diabetes to 20-35% in patients who have 
had diabetes for more than 25 years (Fabre et al., 1982; 
Klein et al., 1988a). 
Clinically diabetic nephropathy initially presents with 
microalbuminuria, defined as albumin excretion ranging 
from 20-200 mg124 hours. After a variable time period, 
the onset of the clinical phase of diabetic nephropathy is 
heralded by the appearance of persisted proteinuria 
(defined as a total protein excretion of 0.5glday or 
more), which is followed by a progressive decline in 
glomerular filtration rate (GFR). The decline in GFR is 
linear over time leading to end stage renal failure. 
Because of this, diabetic nephropathy is the single most 
common cause of renal insufficiency in adults,  
accounting for 15-20% of patients starting renal 
replacement therapy each year (United States Renal Data 
System's 1990 Annual Data Report). 
Epidemiology Metabolic pathogenesis of diabetic nephropathy 
In IDDM the prevalence of nephropathy increases There is clear evidence of a positive relationship 
with duration of diabetes to a peak of 21% after 25 between hyperglycaemia and susceptibility to renal 
years. Following this, the prevalence declines to 10% in disease. Increased susceptibility to long term diabetic 
complications in patients with poor glycaemic control 
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